Based on the one-year price targets offered by 2 analysts, the average target price for Dolby Laboratories Inc (NYSE:DLB) is $100 with a high estimate of $100 and a low estimate of $100.

Barrington analyst Patrick Sholl maintained a Buy rating on Dolby Laboratories (DLB – Research Report) today and set a price target of $100.00. The company’s shares closed yesterday at $80.63.

In a report released yesterday, Steve Frankel from Rosenblatt Securities reiterated a Buy rating on Dolby Laboratories (DLB – Research Report), with a price target of $100.00. The company’s ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study. Although DLB is the second most common neurodegenerative dementia following Alzheimer's ...

A new study from Karolinska Institutet and Mayo Clinic has revealed important insights into brain degeneration in dementia with Lewy bodies (DLB). This research, published in JAMA Neurology ...

Wallpaper’s Ellie Stathaki delves into what defined the 2025 Wallpaper* Architecture Awards Wellbeing and restorative strategies are increasingly coming to the forefront of our efforts to nurture ...

In this article, we are going to take a look at where Dolby Laboratories, Inc. (NYSE:DLB) stands against the other stocks. After two years of substantial gains to record highs, exhaustion in the US ...

Catherine, Jaden, Anne, Phillip, Jamal and Esteban are some of the names that we'll be seeing less of in 2025, a new survey by BabyCenter has revealed. Other names falling in popularity include ...

Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $1.14, expectations were $1.07. Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...